Our latest pharmaceutical market report – ‘The Chinese Medical Devices Market to 2025’ covers pharmaceutical, commercial and strategic developments in the Chinese Medical Devices Market across the next decade. We discuss key markets, key products and how the Chinese Medical Device market operates in general;
Chinese Healthcare spending has risen from $90.8bn in 2004 to reach $590.2bn across 2014, a ten-year CAGR of 20.6%. With increased governmental spend on healthcare, and increasing levels of income for many Chinese citizens, healthcare spend per capita’ is also expected to increase significantly across 2015-2025.
Key growth drivers highlighted within ‘The Chinese Medical Devices Market to 2025’ include; growing customer base, in terms of both increased population and increased numbers of health centres; expanding health insurance; a considerable geriatric population (200m people) and increased incidences of ‘lifestyle’ / non-communicable diseases.
Key restraints in the Chinese Medical devices market include; a fragmented distribution network, that mean that the majority of foreign (non-Chinese) market entrants have had to acquire an existing Chinese medical device manufacturer to gain full market accessibility; variable intellectual property rights /patent protection laws; and differing reimbursement policies.
‘The Chinese Medical Devices Market to 2025’ report concludes with the competitive landscape and Company Profiles of key market players in this market, as of 2015. The market players profiled in this report include GE Healthcare, St. Jude Medical, Medtronic, Stryker, Johnson & Johnson and Boston Scientific. This report also includes the transcript of an exclusive interview with Siemens Healthcare.